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Abstract: Coronavirus disease 2019 (COVID-19) stands out as the major pandemic that we have experienced in the last century. As
it affects every social structure, it brought the importance of intensive care support once again to the agenda of healthcare system
after causing severe acute respiratory syndrome. The precautions to be taken against this virus, where our knowledge is extremely
small, intensive care units take an indispensable place in pandemic planning. In this review, we aimed to emphasize the crucial points
regarding intensive care management of COVID-19 patients, which we have written not only for intensivists but also for all healthcare
professionals.
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1. Introduction
The consequences of coronavirus disease 2019
(COVID-19) caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV 2) which was originated in
Wuhan region of China and spread all over the world, have
influenced all stages of health services. Eventually, World
Health Organization (WHO)1 has declared pandemic for
this virus. This pandemic is accepted as a viral pneumonia
pandemic not a simple flu, therefore, intensive care
unit (ICU) admission, follow-up, and management of
the critically ill patients with COVID-19 is extremely
important. Due to the paucity of studies on COVID-19,
suggestions are generally within the framework of the
experiences gained from China, Italy, USA, and UK that
have the biggest war against this disease. In this review, we
summarized the essential points of ICU management for
COVID-19 patients.1
2. General characteristics of critically ill COVID-19
patients for ICU admission
The need for intensive care might differ according to
institutions or even countries, depending on the demand
and supply ranging from 5% to 32% [1–3]. Severe disease
may present with severe acute respiratory infection
(SARI) i.e. severe pneumonia and acute respiratory

distress syndrome (ARDS) which is reported in 60%–
70% of patients; sepsis and septic shock reported in 30%;
myocarditis, arrhythmia, and cardiogenic shock in 20%–
30%; and acute kidney injury in 10%–30% of patients
[4]. Although respiratory failure is often hypoxemic,
hypercapnic respiratory failure might also be seen mainly
due to mucus plugs. There is a male dominance with
male to female ratio being 2/1 in severe cases, whereas
according to a recent data from Italy, 82% of patients were
male. Although hypertension and diabetes mellitus are the
most common reported comorbidities, advanced age is
also a risk factor for the development of severe disease [5].
The Main ICU admission indications according to Turkish
Guidelines2 (Turkish Public Health General Directorate
Guidelines), which are prepared according to COVID-19
Advisory Committee proposals are shown in Table.
Patients who are hemodynamically stable and do not need
advanced respiratory and organ support anymore might
be transferred to wards [6].
The median time between the initiation of clinical
signs to the development of pneumonia is about 5 days
and the median ICU admission time after development of
hypoxemia is about 7–12 days (1). ICU mortality due to
COVID-19 varies from 16% to 78% according to different
studies [2,5,7–9]. The current reported mortality rate was

1

https://www.who.int/emergencies/diseases/novel-coronavirus-2019

2

https://hsgm.saglik.gov.tr/depo/covid19/rehberler/COVID-19_Rehberi.pdf
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Table. The Main ICU admission indications according to Turkish Guidelines12 (Turkish Public Health General Directorate Guidelines)
Patients with respiratory rate ≥ 30
Dyspnoea and increased work of breathing
SpO2 < 90% or < 70 mm Hg (in room air)
Oxygen requirement ≥ 5L/min with nasal cannula
Lactate > 2 mmol/L
Hypotension (systolic blood pressure (SBP) < 90 mmHg, > 40 mmHg drops from usual SBP, mean arterial pressure (MAP) < 65 mmHg)
Skin hypoperfusion signs
Organ dysfunction such as confusion, kidney and liver tests abnormalities, thrombocytopenia, elevated troponin level and arrhythmia
https://hsgm.saglik.gov.tr/depo/covid19/rehberler/COVID-19_Rehberi.pdf

12

26% in a recent multicentre study from Italy. However, 58%
of patients were still in ICU and only 16% of patients were
able to be discharged which means mortality rate could
be higher [3]. Older age, presence of comorbidities such
as hypertension, diabetes, cardiovascular disease, chronic
lung disease, cancer, higher d-dimer and C-reactive
protein, and lower lymphocyte levels are associated with
higher mortality [4].
3. ICU organization
In part of a pandemic plan of the country and hospitals,
ICU beds should be organized as well as all devices,
equipment, and personnel. It is appropriate to reserve
some ICUs for COVID-19 patients. If this is not possible,
patient cohorts should be done within the ICU. Patients
should be followed in isolated rooms, necessary personnel
protective equipment (PPE) should be provided and a
dedicated team for COVID ICU should be organised. For
this purpose, patient to nurse ratio could be 1:1, if possible.
A stand-by clean medical team may also be considered.
This team can work in other ICUs. It is recommended to
change the team that takes care of COVID-19 patients in
every 14 days. Hereby, a wash-out period is provided. It is
also suggested that health care workers should not work
for longer than 12 h a day in order to minimise risk of
infection. They must be warned that the whole team should
report their body temperature and symptoms twice a day
and they will not leave the city during rest periods [10].
It should be considered that the existing intensive
care beds and organization may not be sufficient due to

the pandemic. Potential solutions are expanding intensive
care outside ICUs, like high-dependency units, general
wards, postanaesthesia care units, and even operating
rooms. On the other hand, surging in the ICU capacity
brings an incremental demand for equipment such as
ventilators, consumable materials, therapeutics and as
well as human force as healthcare workers (HCW). For
this purpose, elective in-patient admissions and surgeries
should be delayed and available wards could be adapted
for stepping down other ICU patients in order to evacuate
ICUs. Another point is to increase HCW trained in
intensive care. Therefore, HCW who are currently working
out of ICU should be systematically trained in terms of
COVID-19 protocol for supporting ICU staff [11].
4. Infection control
To ensure proper infection control measures in the ICU are
crucial. Contact and droplet isolation precautions should
be undertaken3. Faecal-oral transmission has also been
reported4. Viral shedding is expected to be extremely high
in critically ill patients. Interventions such as bag-valvemask ventilation, noninvasive mechanical ventilation
(NIMV), high flow nasal cannula oxygen (HFNO),
nebulisation and oro-tracheal intubation automatically
bring high risk in terms of aerosol production. Expanded
aerosol production might increase airborne transmission
risk as well. That is why airborne isolation (with negative
pressure) should ideally be implemented as soon as possible
in a single room with negative pressure supply that should
be provided at least >12 h/day5.. Fluid-resistant gown, two

Government of Canada. Infection prevention and control for novel coronavirus (2019-nCoV): interim guidance for acute healthcare
settings. https://www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirus- infection/health-professionals/interimguidance-acute-healthcare-settings.html (accessed Februay 2020)
3

XINHUANET. Novel coronavirus may spread via digestive system: experts. English.news.cn. http:// www.xinhuanet.com/english/202002/02/c_138749620.htm (accessed February 2020)
4

WHO. Global surveillance for COVID-19 caused by human infection with COVID-19 virus: interim guidance. https://www. who.int/docs/
default-source/coronaviruse/global-surveillance-for-covid-v-19- nal200321-rev.pdf (accessed March 22, 2020)
5
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longer sleeved gloves to prevent exposure of the wrists with
glove subsiding, eye glasses, full face shield, hair covers
or hood, N95 mask and shoe worn are recommended for
exposure to confirmed or suspected COVID-19 patients.
Disposable shoe covers might increase the risk of selfcontamination during removal of protection clothing and
should be avoided. All ICU team should wear hospital’s
scrubs which should not be worn outside the hospital6.
Zones should be provided for wearing and taking off
properly. Powered air purifying respirators (PAPRs) are
other protective equipment which has not been proven
so far, but it seems reasonable to use in order to decline
the viral transmission. It is more convenient for prolonged
resuscitations [12].
5. Respiratory support
Hypoxemic respiratory failure should be recognized early.
Despite conventional oxygen therapy, increased work of
breathing and hypoxemia could become progressively
worse. Supplemental oxygen should be given via low-flow
O2 delivery systems such as nasal cannula (1-6 L/min to
provide FiO2 of 0.24–0.45), simple face mask (5–8 L/min
to provide FiO2 up to 0.50–0.60), nonrebreather masks
with reservoir providing FiO2 up to > 0.85 with 10–15
L/min oxygen, titrated according to SpO2. Venturi and
diffuser masks are suggested to be avoided. It should be
remembered that FiO2 > 0.60 for > 6 h might create O2
toxicity. HFNO therapy and NIMV support may be applied
in selected hypoxemic respiratory failure cases with proper
PPE because of high risk of aerosol generation. However,
these patients should be followed closely in terms of clinical
deterioration, if no positive response is obtained in the first
few hours (refractory hypoxemia, tachypnoea, tidal volume
(Vt) > 9 mL/kg meaning increased minute ventilation and
work of breathing). When applying NIMV, a helmet mask
may be used, applied with intensive care ventilators or dualcircuit ventilators; a viral/bacterial filter should be added to
the circuit. NIMV should not be applied to patients whose
secretions cannot be controlled; who have high aspiration
risk, impaired mental status, cardiac complications and
multiple organ failure; and who are hemodynamically
unstable [13]. Prolonged spontaneous breathing may cause
uncontrolled intrathoracic negative pressures and induce
patient-self-inflicted lung injury similar to ventilator
induced lung injury and therefore, must be prevented by
utilization of intubation as soon as possible [14].
Almost 10% of patients may require invasive
mechanical ventilation. Endotracheal intubation should

be applied by a trained and most experienced physician
with a rapid sequential intubation protocol. Intubation
should be performed with video-laryngoscope, if possible.
Intubation with flexible bronchoscopy can be used in
difficult intubation. However, bronchoscopy is a high-risk
procedure for aerolisation. Use of bag-mask ventilation
should be avoided during preoxygenation. Preoxygenation
could be performed with nonrebreather mask with
reservoir. If bag-mask would be used, a filter should be
attached to the bag mask. Neuromuscular blockers can
be administered to suppress cough before intubation.
Positive pressure ventilation should not be initiated
before the endotracheal cuff is inflated and patients must
be connected to mechanical ventilator directly without
bag ventilation [15]. Closed system aspiration should be
provided and bacterial/viral filters should be placed in
both inspiratory and expiratory ports of the ventilator.
For airway humidification, heat and moisture exchanger
(HME) filter could be used. Unless absolutely necessary,
bronchoscopic procedures should be avoided and
metered dose inhaler (MDI) should be preferred instead
of nebulization for bronchodilator therapy. However,
due to mucus plugs, and increased resistance and deadspace ventilation, active heated humidifier (HH) can be
preferred7.
In patients developing ARDS, low tidal volumes (4–6
mL/kg) and low inspiratory pressures (plateau pressure < 30
cm H2O, driving pressure which is plateau pressure minus
positive end expiratory pressure < 14 cm H2O) should be
applied. Deep sedation may be required to achieve target
tidal volumes. In terms of low pH like < 7.15, tidal volume
can be increased up to 8 mL/kg. Otherwise permissive
hypercapnia may be allowed [16]. If there is no evidence
of tissue hypoperfusion, conservative fluid support should
be provided. PEEP titration should be applied at pressures
that will prevent atelectotraumas and over distention.
In moderate (PaO2/FiO2 < 200) and severe (PaO2/
FiO2 < 100) ARDS patients, high PEEP may be applied
instead of low PEEP. There is not enough data regarding
recruitment manoeuvres. Even if the use of neuromuscular
blocking agents is not routinely recommended, it can
be applied in the presence of resistant hypoxemia or
hypercapnia, despite sedation in moderate to severe
ARDS with ventilator dyssnchrony and in the first 24–48
h of mechanical ventilation. In patients with PaO2/FiO2
< 150, more than 12 h of prone position could be applied
daily in patients who are managed by conventional MV
interventions. Prone position has been demonstrated to

Government of Canada. Infection prevention and control for novel coronavirus (2019-nCoV): interim guidance for acute healthcare settings.
https://www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirus
infection/health-professionals/interim-guidance-acutehealthcare-settings.html (accessed February 2020)
6

7

https://hsgm.saglik.gov.tr/depo/covid19/rehberler/COVID-19_Rehberi.pdf
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be helpful even in spontaneously breathing nonintubated
patients, even with NIMV and HFNO. Inhaled nitric oxide
(NO) administration could be used as a rescue therapy and
could also theoretically be helpful to improve ventilation/
perfusion match, since it has been speculated that
perfusion is also impaired in ARDS due to COVID-19 and
these patients have preserved compliance. Routine use of
corticosteroids is not recommended [17]. Extracorporeal
membrane oxygenation (ECMO) may be considered in
patients with refractory hypoxemia despite lung-protective
ventilation, and appropriate patients should be referred to
experienced centres. Due to paucity of evidence for this
virus and disease pathophysiology, probable advantages of
ECMO is ambiguous. ECMO is not a therapy that should
be considered in case of a major pandemic regarding the
appropriate allocation of resources [18].
Dr. Gattinoni and his colleagues suggested that
COVID-19 patients with respiratory failure have 2
phenotypes [19]. Phenotype characterized by low elastance
(high compliance), so called Type L, has low ventilator
perfusion ratio, low lung weight, and low recruitability,
whereas Type H, characterized by high elastance (low
compliance) has high right-to-left shunt, high lung
weight, and high recruitability. Severe hypoxemia for high
compliant lungs may be elucidated by the loss of lung
perfusion regulation and hypoxic vasoconstriction. They
recommend to increase FiO2 as a solution for hypoxemia
for those who are not experiencing dyspnoea, in which Type
L patient responds well. Early intubation may even cause
transition to Type H phenotype. However, for intubated
hypercapnic Type L patients, ventilation with more than 6
mL/kg up to 8–9 mL/kg does not bring risk of ventilatorassociated lung injury. Since Type L phenotypes could
have a tolerance in terms of mechanical power by the help
of high compliance. Furthermore, administration of high
PEEP for nonrecruitable lungs may cause hemodynamic
impairment and fluid retention as well. Type H phenotype
looks like usual severe ARDS. Therefore, higher PEEP,
prone positioning, and even extracorporeal support are
classical therapeutic choices. This suggestion has not been
proved in large scale studies and postponing intubation
in severe hypoxemia and increased work of breathing
might be detrimental and early intubation in patients
unresponsive to conventional O2 treatment and perhaps
short course of NIMV and HFNO is recommended.
During weaning from mechanical ventilation, patients
under very low or no sedation should be evaluated for
readiness as such, decreased O2 requirement (FiO2 < 0.40,
PEEP < 8 cm H2O), hemodynamic stability, acceptable
consciousness with preserved gag, and cough reflex. Rapid
shallow breathing index could be checked so that patients
with respiratory rate to tidal volume ratio < 100, have high
likelihood of being successfully weaned from mechanical
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ventilation. Instead of weaning trial through t-piece,
weaning from pressure support ventilation could be chosen
due to less aerosol generation. In COVID-19 patients, high
mucus plugs are being reported, therefore, to reduce the
risk of reintubation timing of weaning and extubation
should be individualized. Whether the cuff leak test should
be performed routinely prior to extubation is unclear. If
postextubation stridor is highly expected (female sex, fluid
overload, prolonged intubation > 5–7 days, age > 80 years,
large endotracheal tubes > 8–8.5 F, difficult and traumatic
intubation), cuff-leak test could be performed weighing
against risks and/or corticosteroids could be given during
extubation. If possible, extubation should be performed
in airborne isolation rooms with maximum PPE use. For
postextubation respiratory failure, NIMV and/or HFNO
should be applied very carefully in selected patients
and if there is stridor, immediate intubation should be
performed. For patients who fail weaning, a tracheostomy
may be indicated which is considered to be a high-risk
procedure for aerosolization [20].
Patients should receive pulmonary and extremity
rehabilitation especially when they have low risk of
infection transmission and meticulous nutritional support
should be provided to prevent ICU-acquired weakness.
6. Management of sepsis and shock
Sepsis is defined as organ failure due to dysregulated host
response accompanying by suspected or documented
infection. Organ failure symptoms and signs are; changes
in consciousness, difficulty breathing, low oxygen
saturation, decreased urine output, increased creatinine
and heart rate, weak pulse, cold extremities or low blood
pressure, signs of coagulopathy, thrombocytopenia,
acidosis, increased lactate level or hyperbilirubinemia.
Septic shock is thought in terms of fluid therapy resistant
hypotension, vasopressor requirement and lactate level
> 2 mmol/L to maintain mean arterial pressure (MAP)
≥ 65 mmHg. It should be remembered that myocarditis
and associated arrhythmias, and cardiogenic shock may be
seen in these patients [21].
Due to lack of evidence, most of the recommendations
are weak or as best practice statements regarding
management of COVID-19 patients with shock. It is
recommended not to use static parameters in order to
assess fluid responsiveness. Dynamic parameters like
skin temperature, capillary refilling time, and/or serum
lactate measurement are suggested. Conservative fluid
management is superior to liberal approach for acute
resuscitation. Buffered/balanced crystalloids are preferred
over unbalanced in the initial treatment. Hydroxyethyl
starch is not suggested which is a strong recommendation.
In addition, gelatines and dextrans should not be used
as well. Routine usage of albumin is not recommended.
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Norepinephrine is the first-line vasoactive agent.
Vasopressin and then adrenalin should be added as a
second-line agent, over titrating norepinephrine dose,
if target MAP cannot be achieved by norepinephrine
alone. Dopamine has no place but could be utilized if
norepinephrine is not available as a last choice. Target
MAP is 60–65 mmHg, rather than higher values. In spite
of fluid resuscitation and norepinephrine, if patients have
persistent cardiac dysfunction and hypoperfusion signs,
dobutamine could be started8.
First hour sepsis bundle should be implemented
as baseline lactate measurement and repeated if first
measurement is >2 mmol/L; blood cultures before
antibiotics and antimicrobial therapy should be started
within 1 h. If bacterial infection is suspected, appropriate
empirical antimicrobial therapy should be initiated. The
choice of antibiotic treatment is made according to the
local epidemiological data and treatment guidelines of
the patient’s clinical condition (community-acquired
pneumonia, healthcare-related pneumonia, comorbidities,
immunosuppression, health care admission in the last
3 months, prior antibiotic use). In intubated patients,
diagnostic tests such as polymerase chain reaction (PCR)
has higher sensitivity if it is done on tracheal aspirates
rather than oro-nasal specimens9. For both corona
PCR and bacterial cultures, tracheal aspirates should be
preferred over bronchoscopic techniques.
Although 30 mL/kg crystalloid (normal saline or ringer
lactate) is suggested in the original bundle, due to the
presence of ARDS fluid treatment should be individualized.
Patients who are hemodynamically unstable, safety of
airway should be provided by taking protective measures.
Patients should not be transferred until stabilization
especially of the airway. If the central catheter cannot be
inserted, vasopressor treatment can be given through the
possible widest vascular access. However, extravasation
should be kept in mind10.
In the critically ill patients, venous thromboembolism
prophylaxis should be undertaken due to immobility.
However, in COVID-19 patients, presence of
hypercoagulopathy is hypothesized and therefore,
therapeutic anticoagulation and perhaps antiaggregant
therapy should be considered in patients with no
contraindications especially in patients with high d-dimer
levels [22].
8

7. Cardiopulmonary resuscitation (CPR)
In case of cardiac arrest, CPR should be managed with as
few people as possible with PPE which must be worn by
all members of the team before entering the room. No
chest compressions or airway procedures should be done
without full PPE use. CPR should be initiated by only chest
compressions which could also be performed by automatic
resuscitators and preoxygenation could be provided with
nonrebreather face masks with reservoir to prevent aerosol
contamination. Recognising the shockable rhythms as
soon as possible and appropriate interventions might
maintain circulation and prevent the need of further
respiratory support like intubation. If bag mask ventilation
and tracheal intubation are needed, at least two physicians
can apply this procedure by the help of oropharyngeal
airway and video-laryngoscope. All procedures should be
debriefed after CPR for personal safety check and patient
clinical evaluation11.
8. Radiology
In the differential diagnosis of COVID-19 pneumonia,
imaging tests should also be used in addition to the
patient’s history, clinical and laboratory findings and
coronavirus specific diagnostic tests. Thorax computerised
tomography (CT) examination can be useful in diagnosis
and can provide important clues in the initial evaluation of
novel coronavirus pneumonia. Multiple patched groundglass opacities in bilateral lobular style, with peripheral
location, are reported as characteristic thorax CT findings
of COVID-19 pneumonia [23]. If CT is not applicable
during ICU stay due to cardiorespiratory instability, lung
ultrasound could be a surrogate imaging method to chest
radiography or CT scanning being a highly sensitive and
specific technique for the diagnosis and follow-up of these
cases [24]. Ultrasound may also be used to make sure the
proper placement of the endotracheal tube and diagnosis
of complications such as pneumothorax [25].
9. Conclusion
In the light of the data obtained from COVID-19 pandemic
and hospital follow-up of these critically ill patients, the
needfulness of intensive care units with well-organized
structure and trained HCW, has emerged once again.
Intensive care science plays a locomotive role in this kind of
outbreak management. The contribution of intensivists who
are dealing with complex organ failures is very important

https://www.sccm.org/getattachment/Disaster/SSC-COVID19-Critical-Care-Guidelines.pdf

WHO. Global surveillance for COVID-19 caused by human infection with COVID-19 virus: interim guidance. https://www. who.int/
docs/default-source/coronaviruse/global-surveillance-for-covid-v-19- nal200321-rev.pdf (accessed March 22, 2020)
9

10

https://hsgm.saglik.gov.tr/depo/covid19/rehberler/COVID-19_Rehberi.pdf

https://www.resus.org.uk/media/statements/resuscitation-council-uk-statements-on-covid-19-coronavirus-cpr-and-resuscitation/covidhealthcare/)
11
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in the training of healthcare professionals for outbreak
planning. Providing the emotional support of HCW while
organising these plans, increasing the motivation by using
the available communication tools is crucial to prevent
burnout by minimizing fear and anxiety [5].
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